Proposed Mechanism of Action (MOA) | TYSABRI® (natalizumab) HCP
Proposed Mechanism of Action (MOA) | TYSABRI® (natalizumab) HCP
Feb 19, 2024
tysabrihcp.com
Nivolumab Ipilimumab Therapy as Frontline Therapy for Advanced Renal Cell Carcinoma | OncLive
Nivolumab Ipilimumab Therapy as Frontline Therapy for Advanced Renal Cell Carcinoma | OncLive
Mar 21, 2022
onclive.com
Pulmozyme® (dornase alfa) Mechanism of Action (MoA)
6:10
Pulmozyme® (dornase alfa) Mechanism of Action (MoA)
Sep 3, 2020
pulmozyme.com
Dana Monroe Discusses Ipilimumab's Side Effects | OncLive
Dana Monroe Discusses Ipilimumab's Side Effects | OncLive
Jun 2, 2011
onclive.com
Ipilimumab is a monoclonal antibody that targets CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), an immune checkpoint protein that inhibits T-cell activity. By blocking CTLA-4, ipilimumab enhances the immune system’s ability to attack cancer cells, making it a type of immune checkpoint inhibitor. It has shown significant efficacy in treating cancers like melanoma, particularly in cases with brain metastases, and is now being explored for other cancers, including glioblastoma (GBM), the mos
1:14
Ipilimumab is a monoclonal antibody that targets CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), an immune checkpoint protein that inhibits T-cell activity. By blocking CTLA-4, ipilimumab enhances the immune system’s ability to attack cancer cells, making it a type of immune checkpoint inhibitor. It has shown significant efficacy in treating cancers like melanoma, particularly in cases with brain metastases, and is now being explored for other cancers, including glioblastoma (GBM), the mos
6.4K views9 months ago
FacebookZain Hasan
Dr. Puzanov on T-VEC in Combination with Ipilimumab for Melanoma Treatment | OncLive
Dr. Puzanov on T-VEC in Combination with Ipilimumab for Melanoma Treatment | OncLive
Jul 9, 2014
onclive.com
Nivolumab Plus Ipilimumab Versus Sunitinib For First-Line Treatment of Advanced Renal Cell Carcinoma: Long-Term Follow-Up Data From the Phase 3 CheckMate 214 Trial | OncLive
6:01
Nivolumab Plus Ipilimumab Versus Sunitinib For First-Line Treatment of Advanced Renal Cell Carcinoma: Long-Term Follow-Up Data From the Phase 3 CheckMate 214 Trial | OncLive
Jan 30, 2024
onclive.com
2:04
Dr Lenz on the FDA Approval of Nivolumab Plus Ipilimumab for dMMR/MSI-H mCRC | OncLive
Apr 8, 2025
onclive.com
3:24
002 Tebentafusp (Kimmtrak) Mechanism of Action
4 views2 weeks ago
YouTubeEye WikiEye وقاية العين
FDA approves expanded uses for immunotherapy
Sep 11, 2017
CBS NewsRobert Preidt
42:48
Immunotherapy for Lung Cancer
14.7K viewsJan 18, 2016
YouTubeGlobal Resource for Advancing Cancer Education
2:18
Long Range Shooting: MOA vs. Mils
24K viewsAug 15, 2019
YouTubeOutdoor Life
1:00:44
Targeting Cancer Pathways: Understanding Immune Checkpoints
37.4K viewsApr 29, 2020
YouTubeCell Signaling Technology, Inc.
3:12
New Immunotherapy Cancer Treatment Opdivo (nivolumab)
4.4K viewsSep 21, 2017
YouTubeLighter Side of Cancer
0:35
Rituximab - Mechanism of Action
37.8K viewsFeb 16, 2018
YouTubeDr Matt & Dr Mike
14:22
Pharmacology - Chemotherapy agents (MOA, Alkalating, antimetabolites, topoisomerase, antimitotic)
746.7K viewsJul 23, 2018
YouTubeArmando Hasudungan
1:57
Dr. Luke Discusses the Controversy Surrounding Ipilimumab/Nivolumab Combo in Melanoma
2.6K viewsApr 3, 2017
YouTubeOncLive
4:50
Ipilimumab/Nivolumab in First-Line mRCC
2.3K viewsApr 23, 2020
YouTubeOncLive
1:51
Checkpoint Inhibitors: Taking the Brakes Off the Immune System
148.5K viewsJun 19, 2015
YouTubeCancer Research Institute
31:02
What is Immunotherapy & Its Mechanisms of Action?
9.6K viewsJan 13, 2016
YouTubeGlobal Resource for Advancing Cancer Education
1:27
Analyzing the Role of Checkpoint Inhibitors for the Treatment of Melanoma
150 viewsMay 1, 2019
YouTubeTargeted Oncology
3:39
Tumor-Related Immune Checkpoints And The Development Of Targeted Cancer Immunotherapies
19.7K viewsDec 28, 2017
YouTubeOriGene Technologies Inc.
0:08
Pronounce Medical Words ― Ipilimumab
2.7K viewsApr 27, 2014
YouTubeMedical 101
2:47
Combination Immunotherapy Animation
13.4K viewsOct 21, 2021
YouTubeRandom42 Scientific Communication
1:38
How to pronounce ipilimumab
1.2K viewsAug 25, 2021
YouTubeBiomedical Pronunciation Guide
0:18
How to Pronounce Ipilimumab
2.9K viewsMar 8, 2015
YouTubePronunciation Guide
1:02
How To Say Ipilimumab
11.5K viewsNov 7, 2017
YouTubeEmma Saying
13:35
Adjuvant Options For Stage III Melanoma
1.5K viewsMay 31, 2023
YouTubeAIMatMelanoma
4:51
HCC: Nivolumab's Side Effects
5.7K viewsFeb 23, 2018
YouTubeOncLive
0:57
Everything About Yervoy (Ipilimumab) - Immunotherapy for Cancer
149 viewsJun 26, 2024
YouTubeMedications For | Anxiety- Diabetes- HTN & M…
See more